Loading…
← CockpitCompetitor Analysis › 4461.T DKS Co. LimitedOpen in the cockpit ↗

DKS Co. Limited4461.TCompetitor analysis, valuation and peers

Japan · JPY·Materials›Chemicals: Specialty
Momentum laggard 7
Mkt cap
$573M
US dollars, full cap
Free float
71%
of shares outstanding
$/day
$43.1M
20-day average traded
Fwd P/E
9.5×
forward earnings
ROIC−WACC
-0.7 pp
WACC 14.6%
Hurdle
+0 pp
Req g minus delivered
Next earnings
71 days
28 Jan 2027
Close · JPY¥9,000
1D+2.6%
1W-13.1%
1M-36.5%
3M-41.1%
6M+2.5%
YTD+9.4%
1Y+34.3%
ATR %11.0%
52w lowhigh47.8% off high

What DKS does

Employees: 1,155

DKS at a glance

Size DKS (4461.T) is a Japan Materials company (Chemicals: Specialty) with a market value of $573M, the 993rd largest of 1,370 Japan companies the cockpit tracks. Shares closed at ¥9,000 on 18 Nov 2026.

Performance Over six months the shares gained 2.5%, against -28.8% for the median peer and -1.4% for the Japan market (cap-weighted) — 4th highest of 21 in its peer set.

Growth Revenue grew 31.4% over the last twelve months (peer median +21.5%); the operating margin is 15.0% (peer median 7.9%).

Valuation It trades at 9.5× forward earnings against a peer median of 11.6× (7th cheapest of 16).

Price implies For today's price to make sense, revenue must grow about 7% a year for seven years (Req g). Recent delivered growth is +7%, so the hurdle is +0 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 0.7 points below its cost of capital (14.6% WACC).

Next results Next results expected around 28 Jan 2027 (exchange calendar; dates can move).

Relative performance

10015021 May 202621 Aug 202618 Nov 20264461.T 101Peer median 66
Six months, rebased to 100: DKS against the median of its 20 peers (local-currency closes).

DKS financials

Reported figures in JPY; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue¥99.1B¥82.9B¥73.3B¥63.1B¥65.1B
Revenue growth—+13%+16%-3%—
Gross profit¥30.9B¥24.5B¥18.0B¥13.2B¥12.8B
EBITDA¥18.1B¥13.3B¥8.57B¥5.29B¥4.56B
Net income¥9.17B¥6.17B¥2.58B¥1.17B-¥406M
Free cash flown/a¥6.34B¥5.39B¥4.59B-¥2.11B
Capital expendituren/a¥3.62B¥2.14B¥2.50B¥2.83B
Total debt¥25.6B¥29.1B¥31.3B¥35.1B¥32.5B

Quarterly statements and history in the cockpit →

DKS competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%121600603790301246300848LCFS4971KOP6038223013956032120026372465IOLCP688386KRNT2851303004784461.T6-month return →1-month return →
Up and to the right = strong over both horizons. DKS is the large dot.

Fundamentals: revenue growth against valuation

0%+50%+100%0×50×100×150×121600300848LCFS4971KOP6038226032120026372465IOLCP688386KRNT0040004461.TRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. DKS is the large dot.

Capital: growth delivered against growth the price implies

0%+50%+100%0%50%100%121600603790LCFS4971KOP603822002637IOLCP3004780040004461.TGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. DKS is the large dot.

DKS competitors and peer comparison

How DKS compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

DKS against its 20 peers (data as of 18 Nov 2026)
Measure4461.TPeer medianRank in peer set
1-month return-36.5%-12.9%lowest of 21
6-month return+2.5%-28.8%4th highest of 21
Distance from 52-week high-47.8%-53.1%9th highest of 21
Revenue growth (TTM)+31.4%+21.5%7th highest of 21
Operating margin15.0%7.9%6th highest of 21
Forward P/E9.5×11.6×7th cheapest of 16
Growth the price implies (Req g, 7 yrs)7.2%4.4%6th least demanding of 11
Growth delivered (Del g)+7.0%+8.9%6th highest of 11
Hurdle (Req g minus delivered)+0.2 pp-1.0 pp6th least demanding of 11
ROIC minus cost of capital-0.7 pp-1.9 pp10th highest of 21
EV / EBITDA5.6×7.6×3rd cheapest of 9
Net debt / EBITDA0.2×0.5×4th least indebted of 9

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
DKS 4461.TJapan$573M+3%+31%15%9.5×7.2%+7.0%
Advanced Nano Products 121600.KSSouth Korea$572M-11%+33%12%47.1×27.9%+18.2%
Argus (Shanghai) Textile Chemicals 603790.SSChina$572M-30%+21%14%n/a10.6%+0.7%
Hubei Hongyuan Pharmaceutical Technology 301246.SZChina$576M-57%+45%12%n/an/an/a
Miracll Chemicals 300848.SZChina$578M-46%+23%1%11.1×n/an/a
Tidewater Renewables LCFS.TOCanada$567M+71%+103%25%11.6×-12.6%+126.4%
MEC 4971.TJapan$582M-52%+31%32%14.7×16.1%+11.9%
Koppers KOPUnited States$563M-24%-1%9%8.0×-3.9%+2.4%
Zhejiang Jiaao Enprotech Stock 603822.SSChina$585M-27%+101%19%7.9×-9.8%+31.6%
Renxin New Material 301395.SZChina$587M+13%+1%-6%n/an/an/a
Cybrid Technologies 603212.SSChina$588M-40%-9%-7%162.9×n/an/a
Zanyu Technology 002637.SZChina$558M-40%-3%3%8.6×-1.8%+11.0%
Jiangsu Lopal Tech 2465.HKHong Kong$590M-61%+107%7%4.8×n/an/a
IOL Chemicals & Pharmaceuticals IOLCP.NSIndia$596M+72%+27%10%22.3×27.1%+3.5%
Pan Asian Microvent Tech (Jiangsu) 688386.SSChina$598M-50%+12%15%36.6×n/an/a
Kornit Digital KRNTUnited States$549M-11%+5%-16%59.3×n/an/a
Skchem 285130.KSSouth Korea$548M-26%+22%0%18.2×n/an/a
Hangzhou Gaoxin Materials Technology 300478.SZChina$600M-21%-21%-9%n/a29.9%-0.9%
Kanto Denka Kogyo 4047.TJapan$546M-24%+28%18%9.5×n/an/a
Jiangsu Baichuan High-Tech New Materials 002455.SZChina$604M-43%+9%1%n/an/an/a
LOTTE Fine Chem 004000.KSSouth Korea$610M-45%+18%7%4.3×-20.1%+6.8%

Questions

Which companies are DKS's closest peers?
The cockpit's peer set: Advanced Nano Products (121600.KS), Argus (Shanghai) Textile Chemicals (603790.SS), Hubei Hongyuan Pharmaceutical Technology (301246.SZ), Miracll Chemicals (300848.SZ), Tidewater Renewables (LCFS.TO), MEC (4971.T), Koppers (KOP), Zhejiang Jiaao Enprotech Stock (603822.SS).
Is DKS expensive compared with its peers?
On forward p/e it trades at 9.5× against a peer median of 11.6×, 7th cheapest of 16 in its peer set. For today's price to make sense, revenue must grow about 7% a year for seven years (Req g). Recent delivered growth is +7%, so the hurdle is +0 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has DKS stock performed?
Over six months to 18 Nov 2026 the shares returned +2.5% against -28.8% for the median peer; over one year +34.3%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.